News on Resverlogix Corporation from BioPortfolio.com http://www.BioPortfolio.com Consolidated Resverlogix Corporation news from BioPortfolio.com Wed, 10 Feb 2010 06:50:38 GMT en Resverlogix completes Phase 2 ASSERT trial enrollment 5 months ahead of schedulehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033936&HITNO=0&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033936&THISHREF=http://c.moreover.com/click/here.pl%3fz2535496593%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033936&HITNO=0&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033936&THISHREF=http://c.moreover.com/click/here.pl%3fz2535496593%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Resverlogix Completes Patient Recruitment for ASSERT Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030950&HITNO=1&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030950&THISHREF=http://c.moreover.com/click/here.pl%3fz2533909174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030950&HITNO=1&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030950&THISHREF=http://c.moreover.com/click/here.pl%3fz2533909174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Resverlogix Completes Patient Recruitment for ASSERT Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031569&HITNO=2&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031569&THISHREF=http://c.moreover.com/click/here.pl%3fz2534267341%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031569&HITNO=2&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031569&THISHREF=http://c.moreover.com/click/here.pl%3fz2534267341%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Resverlogix Completes Patient Recruitment for ASSERT Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029713&HITNO=3&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029713&THISHREF=http://c.moreover.com/click/here.pl%3fz2533240976%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029713&HITNO=3&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029713&THISHREF=http://c.moreover.com/click/here.pl%3fz2533240976%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Higgins Named To Resverlogix Boardhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996844&HITNO=4&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996844&THISHREF=http://c.moreover.com/click/here.pl%3fz2516486981%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996844&HITNO=4&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996844&THISHREF=http://c.moreover.com/click/here.pl%3fz2516486981%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999971&HITNO=5&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999971&THISHREF=http://c.moreover.com/click/here.pl%3fz2517758706%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999971&HITNO=5&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999971&THISHREF=http://c.moreover.com/click/here.pl%3fz2517758706%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991748&HITNO=6&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991748&THISHREF=http://c.moreover.com/click/here.pl%3fz2513852257%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991748&HITNO=6&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991748&THISHREF=http://c.moreover.com/click/here.pl%3fz2513852257%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Resverlogix Announces the Closing of an Additional $8 Million Financinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3979347&HITNO=7&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3979347&THISHREF=http://c.moreover.com/click/here.pl%3fz2505739352%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3979347&HITNO=7&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3979347&THISHREF=http://c.moreover.com/click/here.pl%3fz2505739352%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Resverlogix Presenting at Biotech Showcasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3919646&HITNO=8&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3919646&THISHREF=http://c.moreover.com/click/here.pl%3fz2473560686%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3919646&HITNO=8&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3919646&THISHREF=http://c.moreover.com/click/here.pl%3fz2473560686%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKOTA Territory News: Resverlogix Presenting at Biotech Showcasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3903043&HITNO=9&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3903043&THISHREF=http://c.moreover.com/click/here.pl%3fz2464988698%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3903043&HITNO=9&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3903043&THISHREF=http://c.moreover.com/click/here.pl%3fz2464988698%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Resverlogix Presenting at Biotech Showcasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890956&HITNO=10&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890956&THISHREF=http://c.moreover.com/click/here.pl%3fz2459453595%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890956&HITNO=10&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890956&THISHREF=http://c.moreover.com/click/here.pl%3fz2459453595%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinancials.com: Resverlogix Presenting at Biotech Showcasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3888124&HITNO=11&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3888124&THISHREF=http://c.moreover.com/click/here.pl%3fz2458311535%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3888124&HITNO=11&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3888124&THISHREF=http://c.moreover.com/click/here.pl%3fz2458311535%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Resverlogix Presenting at Biotech Showcasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3887399&HITNO=12&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3887399&THISHREF=http://c.moreover.com/click/here.pl%3fz2458033468%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3887399&HITNO=12&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3887399&THISHREF=http://c.moreover.com/click/here.pl%3fz2458033468%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Resverlogix Presenting at Biotech Showcasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889126&HITNO=13&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889126&THISHREF=http://c.moreover.com/click/here.pl%3fz2458625241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889126&HITNO=13&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889126&THISHREF=http://c.moreover.com/click/here.pl%3fz2458625241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Antonio Business Journal: Resverlogix Presenting at Biotech Showcasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889023&HITNO=14&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889023&THISHREF=http://c.moreover.com/click/here.pl%3fz2458593382%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889023&HITNO=14&MSIZE=74&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Resverlogix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889023&THISHREF=http://c.moreover.com/click/here.pl%3fz2458593382%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Francisco Business Times: